Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

Pope, Melissa, Haase, Ashley T·2003·Nature Medicine

Cited by (354)

Items 101–200 of 354

  1. Sex Differences in the Transmission, Prevention, and Disease Manifestations of Sexually Transmitted Diseases
    Vandana K. Madkan, Angela A. Giancola, Karan K. Sra, Stephen Keith Tyring · 2006 · Archives of Dermatology
  2. Modulation of dendritic cell function by persistent viruses
    Bisheng Liu, Andrea M. Woltman, Harry L.A. Janssen, André Boonstra · 2008 · Journal of Leukocyte Biology
  3. R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models
    Nagadenahalli Byrareddy Siddappa, Jennifer D. Watkins, Klemens J. Wassermann, Ruijiang Song, Wendy Wang, Victor G. Kramer, Samir K. Lakhashe, Michael Santosuosso, Mark C. Poznansky, Francis J. Novembre et al. · 2010 · PLoS ONE
  4. Targeted Delivery of Immunogen to Primate M Cells with Tetragalloyl Lysine Dendrimer
    Misumi, Shogo, Masuyama, Mitsuaki, Takamune, Nobutoki, Nakayama, Daisuke, Mitsumata, Ryotarou, Matsumoto, Hirokazu, Urata, Norimitsu, Takahashi, Yoshihiro, Muneoka, Atsunobu, Sukamoto, Takayuki et al. · 2009 · The Journal of Immunology
  5. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
    Fabrizio Ensoli, Aurelio Cafaro, Anna Casabianca, Antonella Tripiciano, Stefania Bellino, Olimpia Longo, Vittorio Francavilla, Orietta Picconi, Cecilia Sgadari, Sonia Moretti et al. · 2015 · Retrovirology
  6. How Do Viral and Host Factors Modulate the Sexual Transmission of HIV? Can Transmission Be Blocked?
    Kalpana Gupta, Per Johan Klasse · 2006 · PLoS Medicine
  7. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract
    Donita Africander, Renate Louw-du Toit, Nicolette J. D. Verhoog, Dewald Johan Noeth, Janet Patricia Hapgood · 2011 · Contraception
  8. Immunodeficiency virus exploitation of dendritic cells in the early steps of infection
    Natalia Teleshova, Ines Frank, Melissa Pope · 2003 · Journal of Leukocyte Biology
  9. The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
    Silvija I. Staprans, Mark B. Feinberg · 2004 · Expert Review of Vaccines
  10. HIV vaccines: progress to date.
    Cynthia Mee Ling Munier, Chris Andersen, Anthony Dominic Kelleher · 2011 · PubMed
  11. Human Immunodeficiency Virus Type 1 and Influenza Virus Exit via Different Membrane Microdomains
    Sandhya Khurana, Dimitry N. Krementsov, Aymeric de Parseval, John H. Elder, Michelangelo Foti, Markus Thali · 2007 · Journal of Virology
  12. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR649–684, a mucosal subunit HIV/AIDS vaccine candidate
    Nobuyuki Matoba, Brian C. Geyer, Jacquelyn A. Kilbourne, Annette Alfsen, Morgane Bomsel, Tsafrir S. Mor · 2006 · Vaccine
  13. Intermittent low-level viremia in very early primary HIV-1 infection.
    Eberhard W. Fiebig, Charles M. Heldebrant, Richard I F Smith, Andrew J Conrad, Eric Delwart, Michael Paul Busch · 2005 · PubMed
  14. The Effects of Latent Infection on the Dynamics of HIV
    Stephen Pankavich · 2015 · Differential Equations and Dynamical Systems
  15. Mucosal Priming with a Replicating-Vaccinia Virus-Based Vaccine Elicits Protective Immunity to Simian Immunodeficiency Virus Challenge in Rhesus Monkeys
    Caijun Sun, Zhiwei Chen, Xian Tang, Yinfeng Zhang, Liqiang Feng, Yanhua Du, Lijun Xiao, Li Liu, Weijun Zhu, Ling Chen et al. · 2013 · Journal of Virology
  16. HMGB1-Dependent Triggering of HIV-1 Replication and Persistence in Dendritic Cells as a Consequence of NK-DC Cross-Talk
    Héla Saïdi, Marie‐Thérèse Melki, Marie‐Lise Gougeon · 2008 · PLoS ONE
  17. The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind’s future?
    Natasja G. de Groot, Ronald E. Bontrop · 2013 · Retrovirology
  18. Nano-engineered screen-printed electrodes: A dynamic tool for detection of viruses
    Mazhar Sher, Aroosha Faheem, Waseem Asghar, Stefano Cinti · 2021 · TrAC Trends in Analytical Chemistry
  19. Microbicides—aids to safer sex
    Robin J. Shattock, Suniti Solomon · 2004 · The Lancet
  20. Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection
    Sandra Milena González, Wbeimar Aguilar-Jiménez, Ruey‐Chyi Su, Marı́a Teresa Rugeles · 2019 · Frontiers in Immunology
  21. Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy
    Eva Poveda, Verónica Briz, Carmen de Mendoza, Jose Miguel Benito, Angélica Corral, Natalia Zahonero, Sara Lozano, Juan González‐Lahoz, Vincent Soriano · 2007 · Journal of Medical Virology
  22. HIV-1 proteins gp120 and tat induce the epithelial–mesenchymal transition in oral and genital mucosal epithelial cells
    Kathy Lien, Mayer Wasima, Rossana Herrera, Kristina W. Rosbe, Sharof M. Tugizov · 2019 · PLoS ONE
  23. CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
    Mary S. Pampusch, Hadia M. Abdelaal, Emily Kathleen Cartwright, Jhomary S. Molden, Brianna C. Davey, Jordan D. Sauve, Emily N. Sevcik, Aaron Rendahl, Eva G. Rakasz, Elizabeth Connick et al. · 2022 · PLoS Pathogens
  24. HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
    Nobuyuki Matoba, Adam S. Husk, Brian W. Barnett, Michelle M. Pickel, Charles J. Arntzen, David C. Montefiori, Atsushi Takahashi, Kazunobu Tanno, Satoshi Ōmura, Huyen Cao et al. · 2010 · PLoS ONE
  25. Exploiting common targets in human fertilization and HIV infection: development of novel contraceptive microbicides
    Gustavo F. Doncel · 2005 · Human Reproduction Update
  26. Detection of Intraepithelial and Stromal Langerin and CCR5 Positive Cells in the Human Endometrium: Potential Targets for HIV Infection
    Tove Kaldensjö, Pernilla Petersson, Anna Tolf, Gareth Morgan, Kristina Broliden, Taha Hirbod · 2011 · PLoS ONE
  27. DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4
    Karolin Hijazi, Yufei Wang, Carlo Scala, S. A. Jeffs, Colin Longstaff, Daniel J Stieh, Beth Haggarty, Guido Vanham, Dominique Schols, Jan M. Balzarini et al. · 2011 · PLoS ONE
  28. The Role of Defensins in HIV Pathogenesis
    Barcley T. Pace, Andrew A. Lackner, Edith Martin Porter, Bapi Pahar · 2017 · Mediators of Inflammation
  29. Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis
    Diana Finzi, Susan F. Plaeger, Carl W. Dieffenbach · 2006 · Clinical and Vaccine Immunology
  30. Porphyromonas gingivalis Selectively Up-Regulates the HIV-1 Coreceptor CCR5 in Oral Keratinocytes
    Rodrigo A. Giacaman, Angela H. Nobbs, Karen F. Ross, Mark C. Herzberg · 2007 · The Journal of Immunology
  31. Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
    Daniel B. Reeves, Yunda Huang, Elizabeth R. Duke, Bryan T. Mayer, Erwing Fabian Cardozo Ojeda, Florencia A. T. Boshier, David A. Swan, Morgane Rolland, Merlin Lee Robb, John R. Mascola et al. · 2020 · PLoS Computational Biology
  32. Functional Mimicry of a Human Immunodeficiency Virus Type 1 Coreceptor by a Neutralizing Monoclonal Antibody
    Shi-Hua Xiang, Michael Farzan, Zhihai Si, Navid Madani, Liping Wang, Eric S. Rosenberg, James E. Robinson, Joseph Sodroski · 2005 · Journal of Virology
  33. Herpes Simplex Virus-Induced Epithelial Damage and Susceptibility to Human Immunodeficiency Virus Type 1 Infection in Human Cervical Organ Culture
    Julie Horbul, Stephen C. Schmechel, Barrie R. L. Miller, Stephen A. Rice, Peter J. Southern · 2011 · PLoS ONE
  34. Optimal use of maraviroc in clinical practice
    Vincent Soriano, Anna María Geretti, Carlo Federico Perno, Gerd Fätkenheuer, Deenan Pillay, Jacques Reynes, Giuseppe Tambussi, Vincent Cálvez, José Alcamı́, Juergen Rockstroh · 2008 · AIDS
  35. The probability of HIV infection in a new host and its reduction with microbicides
    Henry C. Tuckwell, Patrick D. Shipman, Alan S. Perelson · 2008 · Mathematical Biosciences
  36. Semen Protects CD4+ Target Cells from HIV Infection but Promotes the Preferential Transmission of R5 Tropic HIV
    Emmanuel Balandya, Siddharth H Sheth, Katherine M. Sanders, Wendy Wieland‐Alter, Timothy Lahey · 2010 · The Journal of Immunology
  37. Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources
    John B. Patton, Raja Vuyyuru, Amanda E. Siglin, Michael J. Root, Tim L. Manser · 2015 · Journal of Immunological Methods
  38. Gaining a foothold: how HIV avoids innate immune recognition
    Nan Yan, Judy Lieberman · 2010 · Current Opinion in Immunology
  39. A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations
    Jorma Hinkula, Claudia Devito, Bartek Zuber, Reinhold Benthin, Denise Alves Ferreira, Britta Wahrén, Ulf Schröder · 2005 · Vaccine
  40. Liposomes for HIV prophylaxis
    Nikita K. Malavia, David Zurakowski, Avi Schroeder, Amy M. Princiotto, Anna Ray Laury, Hila Epstein-Barash, Joseph Sodroski, Róbert Langer, Navid Madani, Daniel S. Kohane · 2011 · Biomaterials
  41. Galectin-1 and HIV-1 Infection
    Christian St-Pierre, Michel Ouellet, Michel J. Tremblay, Sachiko Sato · 2010 · Methods in enzymology on CD-ROM/Methods in enzymology
  42. Mucosal Innate Immune Response Associated with a Timely Humoral Immune Response and Slower Disease Progression after Oral Transmission of Simian Immunodeficiency Virus to Rhesus Macaques
    Jeffrey M. Milush, Kelly Stefano-Cole, Kimberli A. Schmidt, Andre Durudas, Ivona Pandrea, Donald L. Sodora · 2007 · Journal of Virology
  43. Treatment of HIV infection with the CCR5 antagonist maraviroc
    W. Kromdijk, Alwin D. R. Huitema, Jan Willem Mulder · 2010 · Expert Opinion on Pharmacotherapy
  44. Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues
    Jason Ho, Susan L. Moir, Liudmila N. Kulik, Angela Malaspina, Eileen T. Donoghue, Natalie J. Miller, Wei Wang, Tae‐Wook Chun, Anthony S. Fauci, Vernon Michael Holers · 2007 · The Journal of Immunology
  45. Cell-to-Cell Spread of HIV and Viral Pathogenesis
    Kenneth Law, Namita Satija, Anthony M. Esposito, Benjamin K. Chen · 2016 · Advances in virus research
  46. A REVIEW ON: HIV AIDS
    Kapila A, Sangeeta Chaudhary, Sharma Rb, H Vashist, Sisodia SS, Amod Gupta · 2016 · Indian Journal of Pharmaceutical and Biological Research
  47. Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1
    Fedde Groot, Taco Willem Kuijpers, Ben Berkhout, Esther C. de Jong · 2006 · Retrovirology
  48. HIV ‐1 Vaginal Transmission: Cell‐Free or Cell‐Associated Virus?
    Victor Barreto‐de‐Souza, Anush Arakelyan, Leonid B Margolis, Christophe Vanpouille · 2014 · American Journal of Reproductive Immunology
  49. Thermosensitive hydrogels a versatile concept adapted to vaginal drug delivery
    Sébastien Taurin, Aliyah A. Almomen, Tatianna Pollak, Sun Jin Kim, John Maxwell, C. Matthew Peterson, Shawn C. Owen, Margit Maria Janat-Amsbury · 2017 · Journal of drug targeting
  50. HIV and AIDS: looking ahead
    Robin A. Weiss · 2003 · Nature Medicine
  51. Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
    David A. Spencer, Benjamin S. Goldberg, Shilpi Pandey, Tracy Cheever, Jérémy Dufloo, Philip T. Barnette, William F. Sutton, Heidi Henderson, Rebecca Agnor, Lina Gao et al. · 2022 · Nature Communications
  52. HIV's Vagina Travelogue
    César Boggiano, Dan R. Littman · 2007 · Immunity
  53. The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis
    Sarah E. Hochman, Kami Kim · 2012 · Journal of Neuroparasitology
  54. SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell‐mediated HIV transmission
    Theresa Li-Yun Chang, Natalia Teleshova, Aprille Rapista, Maciej T. Paluch, Robert A. Anderson, Donald P. Waller, Lourens J. D. Zaneveld, Angela Granelli‐Piperno, Mary E. Klotman · 2007 · FEBS Letters
  55. Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load
    Victor G. Kramer, Susan M. Schader, Maureen Oliveira, Susan P. Colby-Germinario, Daniel Aaron Donahue, Diane N. Singhroy, Randy Tressler, Richard D. Sloan, Mark A. Wainberg · 2012 · Antimicrobial Agents and Chemotherapy
  56. Mucosal Tissue Tropism and Dissemination of HIV-1 Subtype B Acute Envelope-Expressing Chimeric Virus
    Deborah F. L. King, Asna A. Siddiqui, Viviana Buffa, Lucia Fischetti, Yong Gao, Daniel J Stieh, Paul F. McKay, Paul Rogers, Christina Ochsenbauer, John C. Kappes et al. · 2012 · Journal of Virology
  57. Pathogenesis of HIV Disease: Opportunities for New Prevention Interventions
    Anthony S. Fauci · 2007 · Clinical Infectious Diseases
  58. A Model System of Oral HIV Exposure, Using Human Palatine Tonsil, Reveals Extensive Binding of HIV Infectivity, with Limited Progression to Primary Infection
    Diane M. Maher, Xiaoyun Wu, Timothy W. Schacker, Matthew C. Larson, Peter J. Southern · 2004 · The Journal of Infectious Diseases
  59. Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection
    Katja Klein, Gabrielle C. Nickel, Immaculate Nankya, Fred Kyeyune, Korey Demers, Emmanuel Ndashimye, Cynthia Kwok, Pai‐Lien Chen, Sandra Rwambuya, Art F. Y. Poon et al. · 2018 · PLoS Pathogens
  60. In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 against NNRTI-Resistant Human Immunodeficiency Virus Type 1
    Mohammad Mokbul Hossain, Michael A. Parniak · 2006 · Journal of Virology
  61. A Noninfectious Simian/Human Immunodeficiency Virus DNA Vaccine That Protects Macaques against AIDS
    Dinesh Kumar Singh, Zhenqian Liu, Darlene Sheffer, Glenn A. Mackay, Marilyn S. Smith, Sukhbir Dhillon, Ramakrishna Hegde, Fenglan Jia, Istvan Adany, Opendra Narayan · 2005 · Journal of Virology
  62. Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes
    Margarida Rodrigues, Beatriz G. de la Torre, David Andreu, Nuno C. Santos · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
  63. Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
    Olga Latinovic, Janaki C. Kuruppu, Charles E. L. B. Davis, Nhut M. Le, Alonso Heredia · 2009 · Clinical Medicine Therapeutics
  64. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance
    Mayur C. Tamhane, Ramesh Akkina · 2008 · AIDS Research and Therapy
  65. Systemic and mucosal immunological responses during repeated mucosal SHIV162P3 challenges prior to and following infection in pigtailed macaques
    Nattawan Promadej‐Lanier, Priya Srinivasan, Kelly A. Curtis, Debra R. Adams, Caryn Kim, Wei Luo, Hongwei Jia, Shambavi Subbarao, Ron A. Otten, Sal Butera · 2008 · Virology
  66. Ex Vivo Modeling of Oral HIV Transmission in Human Palatine Tonsil
    Diane M. Maher, Zhi-Qiang Zhang, Timothy W. Schacker, Peter J. Southern · 2005 · Journal of Histochemistry & Cytochemistry
  67. CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable
    Kristin A. Agopian, Bangdong L. Wei, J. Victor Garcia, Dana H. Gabuzda · 2006 · Virology
  68. Activation by Inflammatory Stimuli Increases Neutrophil Binding of Human Immunodeficiency Virus Type 1 and Subsequent Infection of Lymphocytes
    Ali Gabali, Joshua James Anzinger, Gregory T. Spear, Larry L. Thomas · 2004 · Journal of Virology
  69. Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection
    Samir K. Lakhashe, Wendy Wang, Nagadenahalli Byrareddy Siddappa, Girish Hemashettar, Patricia S. Polacino, Shiu-Lok Hu, Francois J. Villinger, James G. Else, Francis J. Novembre, John K. Yoon et al. · 2011 · PLoS ONE
  70. Saquinavir Inhibits Early Events Associated with Establishment of HIV-1 Infection: Potential Role for Protease Inhibitors in Prevention
    Martha Stefanidou, Carolina Herrera, Naomi Armanasco, Robin J. Shattock · 2012 · Antimicrobial Agents and Chemotherapy
  71. Topical microbicides: a promising approach for controlling the AIDS pandemic via retroviral zinc finger inhibitors.
    J. Turpin, M. Schito, L. M. Miller Jenkins, J. Inman, E. Appella · 2008 · Advances in Pharmacology
  72. Animal models in virus research: their utility and limitations
    Derrick Louz, Hans E. N. Bergmans, Birgit P. Loos, Rob C. Hoeben · 2012 · Critical Reviews in Microbiology
  73. Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells
    Bangxing Hong, Xiao‐Tong Song, Lisa A. Rollins, Lindsey Berry, Xue F. Huang, Si Yi Chen · 2011 · Journal of Clinical Investigation
  74. Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity
    Lingshu Wang, Cheng Cheng, Sung‐Youl Ko, Wing‐Pui Kong, Masaru Kanekiyo, David A. Einfeld, Richard M. Schwartz, C. Richter King, Jason G. D. Gall, Gary J. Nabel · 2009 · Journal of Virology
  75. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat
    David C. Montefiori, Maria V. Filsinger Interrante, Benjamin N. Bell, Adonis A. Rubio, Joseph G. Joyce, John W. Shiver, Celia C. LaBranche, Peter S. Kim · 2021 · Proceedings of the National Academy of Sciences
  76. Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses
    Andreas Bråve, David Hallengärd, Ulf Schröder, Pontus Blomberg, Britta Wahrén, Jorma Hinkula · 2008 · Vaccine
  77. The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry
    Jason Grant Williams, Kenneth B. Tomer, Catarina E. Hioe, Susan Zolla‐Pazner, Philip J. Norris · 2006 · Journal of the American Society for Mass Spectrometry
  78. Fetal Immune Activation to Malaria Antigens Enhances Susceptibility to In Vitro HIV Infection in Cord Blood Mononuclear Cells
    Kevin Steiner, Latoya Myrie, Indu J. Malhotra, Peter Mungai, Eric M. Muchiri, Arlene E. Dent, Christopher L. King · 2010 · The Journal of Infectious Diseases
  79. Progress towards an AIDS mucosal vaccine: An overview
    Yoshikazu Yuki, Tomonori Nochi, Hiroshi Kiyono · 2007 · Tuberculosis
  80. HIV‐1 negatively affects the survival/maturation of cord blood CD34+ hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV‐1 gp120/CD4 membrane interaction
    Davide Gibellini, Francesca Vitone, Marina Buzzi, Pasqua Schiavone, Elisa De Crignis, Ronny Cicola, Roberto Conte, Cristina Ponti, Maria Carla Re · 2006 · Journal of Cellular Physiology
  81. Macaque Dendritic Cells Infected with SIV-Recombinant Canarypox ex Vivo Induce SIV-Specific Immune Responses in Vivo
    Loreley Villamide, Ralf Ignatius, Michael A. Eller, K. Wilkinson, C. Griffin, Erin Mehlhop, Jennifer Jones, Seol-Young Han, Mark G. Lewis, Stephanie Parrish et al. · 2004 · AIDS Research and Human Retroviruses
  82. Spatial Aspects of HIV Infection
    Frederik Graw, Alan S. Perelson · 2012 · Lecture notes on mathematical modelling in the life sciences
  83. Role of host-encoded proteins in restriction of retroviral integration
    Yasutsugu Suzuki, Mun Lok Chew, Youichi Suzuki · 2012 · Frontiers in Microbiology
  84. Syndecan-Fc Hybrid Molecule as a PotentIn VitroMicrobicidal Anti-HIV-1 Agent
    Michael D. Bobardt, Udayan Chatterji, Lana Schaffer, Lot D. de Witte, Philippe A. Gallay · 2010 · Antimicrobial Agents and Chemotherapy
  85. Avances en el diagnóstico y tratamiento de la infección aguda por el VIH-1
    José M. Miró, Omar Gustavo Sued, Montserrat Plana, Tomàs Pumarola, Teresa Gallart · 2004 · Enfermedades Infecciosas y Microbiología Clínica
  86. A recombinant allosteric lectin antagonist of HIV‐1 envelope gp120 interactions
    Karyn McFadden, Simon Cocklin, Hosahudya N. Gopi, Sabine Baxter, Sandya Ajith, Naheed Mahmood, Robin J. Shattock, IRWIN M. CHAIKEN · 2007 · Proteins Structure Function and Bioinformatics
  87. Detection of HIV-1 RNA/DNA and CD4 mRNA in feces and urine from chronic HIV-1 infected subjects with and without anti-retroviral therapy
    Ayan K. Chakrabarti, Lori Caruso, Ming Ding, Chengli Shen, William Buchanan, Phalguni Gupta, Charles R. Rinaldo, Yue Chen · 2009 · AIDS Research and Therapy
  88. High frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil
    Cristina Mendes de Oliveira, Flávia Jacqueline Almeida, Rosangela Felipe Rodrigues, Márcia Terezinha Lonardoni Crozatti, Carla Maria Pasquareli Vazquez, Maria do Socorro Carneiro Ferrão, Alexandre Ely Campéas, Silvia Regina Marques, Eitan Naaman Berezin, Luís Fernando de Macedo Brígido · 2008 · Archives of Virology
  89. Optimal control of combined antiretroviral therapies in an HIV infection model with cure rate and fusion effect
    Bhagya Jyoti Nath, Kaushik Dehingia, Khadijeh Sadri, Hemanta Kumar Sarmah, KAMYAR HOSSEINI, Choonkil Park · 2022 · International Journal of Biomathematics
  90. Dendritic Cells Derived from Hemozoin-Loaded Monocytes Display a Partial Maturation Phenotype that Promotes HIV-1 Trans -Infection of CD4+ T Cells and Virus Replication
    Juliette Diou, Mélanie R. Tardif, Corinne Barat, Michel J. Tremblay · 2010 · The Journal of Immunology
  91. Design of dietary polysaccharide and binary monomer mixture of acrylamide and 2-acrylamido-2-methylpropane sulphonic acid based antiviral drug delivery devices
    Baljit Singh, Ritu Bala · 2011 · Process Safety and Environmental Protection
  92. Parameters of inhibition of HIV-1 infection by small anionic microbicides
    Andrei N. Vzorov, Jadranka Bozja, Dabney White Dixon, Luigi G. Marzilli, Richard W. Compans · 2006 · Antiviral Research
  93. Microbicides: A new hope for HIV prevention
    Gupta Sk, Nutan Nutan · 2011 · The Indian Journal of Medical Research
  94. Minimum infective dose of HIV for parenteral dosimetry
    Savanna R Reid, O A Juma · 2009 · International Journal of STD & AIDS
  95. Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity
    Valérie Lorin, Marine Malbec, Caroline Eden, Timothée Bruel, Françoise Porrot, Michael S. Seaman, Olivier Schwartz, Hugo Mouquet · 2016 · Mucosal Immunology
  96. Implant delivering hydroxychloroquine attenuates vaginal T lymphocyte activation and inflammation
    Yufei Andy Chen, Yannick Léandre Traoré, Sidi Yang, Julie Lajoie, Keith Raymond Fowke, Daniel W. Rickey, Emmanuel A. Ho · 2018 · Journal of Controlled Release
  97. Enhanced Replication of R5 HIV-1 Over X4 HIV-1 in CD4+CCR5+CXCR4+ T Cells
    Ann-Marie M. Roy, Becky Schweighardt, Lauren A. Eckstein, Mark A. Goldsmith, J M McCune · 2005 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  98. Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques
    Marion S. Ratterree, Agegnehu Gettie, Victoria Williams, Susan E. Malenbaum, A. ROBERT NEURATH, Cecilia Cheng‐Mayer, James Blanchard · 2005 · AIDS
  99. Development of a tier 1 R5 clade C simian–human immunodeficiency virus as a tool to test neutralizing antibody‐based immunoprophylaxis
    Nagadenahalli Byrareddy Siddappa, Girish Hemashettar, Yin Ling Wong, Samir K. Lakhashe, Robert A. Rasmussen, Jennifer D. Watkins, Francis J. Novembre, Francois J. Villinger, James G. Else, David C. Montefiori et al. · 2010 · Journal of Medical Primatology
  100. Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
    Sikhulile M. Moyo, Alain M. Vandormael, Eduan Wilkinson, Susan Engelbrecht, Simani Gaseitsiwe, Kenanao Peggy Kotokwe, Rosemary Mubanga Musonda, Frank Courteney Tanser, Max Essex, Vladimir Novitsky et al. · 2016 · PLoS ONE